PATENT CLAIM ANALYSIS

Application Number: 15962814
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "359000"]

Abstract:
The invention relates to compounds which are mGlu2/3 negative allosteric modulators for use in the treatment of intellectual disabilities. In another aspect, the invention relates to a pharmaceutical composition for use in the treatment of intellectual disabilities comprising a compound according to the invention and a pharmaceutically acceptable carrier.

Claim (Index 6):
A pharmaceutical composition comprising a mGlu2/3 negative allosteric modulator according to  claim 1  or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.52941
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12053648', '13178531', '12551625', '11726575', '12394083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7222306554786434
- 35 USC 102 Novelty (BERT): 0.5108706223797465
- Combined Prediction Score: 0.7010946521687538
- Mean Citation Score: 237.48939600000003
- Max Citation Score: 243.01498
- Similarity Product: 160.57958639644502

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test